Robert E. Schmidt
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Robert E. Schmidt has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
Denise A. Dorsey
7 shared publicationsLucie N. Beaudet
6 shared publicationsCurtis A. Parvin
5 shared publicationsDenise A Dorsey
Department of Pathology, Division of Neuropathology, Saint Louis, MO 63110, USA
3 shared publicationsSantiago B. Plurad
From the Departments of Pathology and Immunology,*Divisions of Neuropathology and Laboratory Medicine,†and Medicine,‡Division of Metabolism, Washington University School of Medicine, St. Louis, Missouri
3 shared publicationsCurtis A Parvin
Laboratory Medicine Washington University, School of Medicine, Saint Louis, MO 63110, USA
2 shared publications
Latest Publications
- Open Access
- 31 January 2015
- Published by Springer Nature in Radiation Oncology
- Vol. 10 (1) , 33
Perilesional edema in radiation necrosis reflects axonal degeneration
Recently, we characterized a Gamma Knife® radiation necrosis mouse model with various magnetic resonance imaging (MRI) protocols to identify biomarkers useful in differentiation from tumors. Though the irradiation was focal to one hemisphere, a contralateral injury was observed that appeared to be localized in the white matter only. Interestingly, this injury was identifiable in T2-weighted images, apparent diffusion coefficient (ADC), and magnetization transfer ratio (MTR) maps, but not on post-contrast T1-weighted images. This observation of edema independent of vascular changes is akin to the perilesional edema seen in clinical radiation necrosis. The pathology underlying the observed white-matter MRI changes was explored by performing immunohistochemistry for healthy axons and myelin. The presence of both healthy axons and myelin was reduced in the contralateral white-matter lesion. Based on our immunohistochemical findings, the contralateral white-matter injury is most likely due to axonal degeneration.
- 31 January 2015
- Published by Springer Nature in Radiation Oncology
- Vol. 10 (1) , 33
Open AccessPerilesional edema in radiation necrosis reflects axonal degeneration
Recently, we characterized a Gamma Knife® radiation necrosis mouse model with various magnetic resonance imaging (MRI) protocols to identify biomarkers useful in differentiation from tumors. Though the irradiation was focal to one hemisphere, a contralateral injury was observed that appeared to be localized in the white matter only. Interestingly, this injury was identifiable in T2-weighted images, apparent diffusion coefficient (ADC), and magnetization transfer ratio (MTR) maps, but not on post-contrast T1-weighted images. This observation of edema independent of vascular changes is akin to the perilesional edema seen in clinical radiation necrosis. The pathology underlying the observed white-matter MRI changes was explored by performing immunohistochemistry for healthy axons and myelin. The presence of both healthy axons and myelin was reduced in the contralateral white-matter lesion. Based on our immunohistochemical findings, the contralateral white-matter injury is most likely due to axonal degeneration.
- 10 January 2010
- Published by Taylor & Francis in Expert Review of Endocrinology & Metabolism
- Vol. 5 (1) , 39-49
Mitochondrial stress and the pathogenesis of diabetic neuropathy
Diabetic neuropathy is a major complication of diabetes that affects the sensory and autonomic nervous systems and leads to significant morbidity and impact on the quality of life of patients. Mito...
- 10 January 2010
- Published by Taylor & Francis in Expert Review of Endocrinology & Metabolism
- Vol. 5 (1) , 39-49
Mitochondrial stress and the pathogenesis of diabetic neuropathy
Diabetic neuropathy is a major complication of diabetes that affects the sensory and autonomic nervous systems and leads to significant morbidity and impact on the quality of life of patients. Mito...
- 31 October 2006
- Published by Elsevier in Neurobiology of Aging
- Vol. 27 (10) , 1514-1523
Sympathetic neuroaxonal dystrophy in the aged rat pineal gland
- 31 October 2006
- Published by Elsevier in Neurobiology of Aging
- Vol. 27 (10) , 1514-1523
Sympathetic neuroaxonal dystrophy in the aged rat pineal gland
- Open Access
- 1 November 2004
- Published by Oxford University Press (OUP) in Journal of Neuropathology & Experimental Neurology
- Vol. 63 (11) , 1144-1154
Ganglion-Specific Patterns of Diabetes-Modulated Gene Expression Are Established in Prevertebral and Paravertebral Sympathetic Ganglia Prior to the Development of Neuroaxonal Dystrophy
In both humans and animal models, diabetic sympathetic autonomic neuropathy is associated with the selective development of markedly enlarged distal axons and nerve terminals (neuroaxonal dystrophy, NAD). NAD occurs in the prevertebral superior mesenteric and celiac ganglia (SMG-CG), but not in the paravertebral superior cervical ganglion (SCG). To identify molecular differences between these ganglia that may explain their selective vulnerability to NAD, we have examined global gene expression patterns in control and diabetic rat sympathetic ganglia before and after the onset of structural evidence of NAD. As predicted, major differences in transcriptional profiles exist between SCG and SMG-CG in normal young adult animals including, but not limited to, known differences in neurotransmitter-related gene expression. Gene expression patterns of diabetic SMG-CG and SCG, prior to the development of NAD lesions, also differ from their age-matched non-diabetic counterparts. However, diabetes has ganglion-specific effects on gene expression; of approximately 110 transcripts that were differentially expressed between diabetic and control sympathetic ganglia, only 5 were differentially expressed as a result of diabetes in both SCG and SMG-CG. Genes involving synapse and mitochondrial structure and function, oxidative stress, and glycolysis were highly represented in the differentially expressed gene set. Differences in the number of synapse-related gene alterations in diabetic SMG-CG (18 genes) versus SCG (2 genes) prior to the onset of NAD may also well explain the selective development of NAD in the SMG-CG. These results provide support for the specificity of diabetes-modulated gene expression for selected neuronal subpopulations of sympathetic noradrenergic neurons.
- 1 November 2004
- Published by Oxford University Press (OUP) in Journal of Neuropathology & Experimental Neurology
- Vol. 63 (11) , 1144-1154
Open AccessGanglion-Specific Patterns of Diabetes-Modulated Gene Expression Are Established in Prevertebral and Paravertebral Sympathetic Ganglia Prior to the Development of Neuroaxonal Dystrophy
In both humans and animal models, diabetic sympathetic autonomic neuropathy is associated with the selective development of markedly enlarged distal axons and nerve terminals (neuroaxonal dystrophy, NAD). NAD occurs in the prevertebral superior mesenteric and celiac ganglia (SMG-CG), but not in the paravertebral superior cervical ganglion (SCG). To identify molecular differences between these ganglia that may explain their selective vulnerability to NAD, we have examined global gene expression patterns in control and diabetic rat sympathetic ganglia before and after the onset of structural evidence of NAD. As predicted, major differences in transcriptional profiles exist between SCG and SMG-CG in normal young adult animals including, but not limited to, known differences in neurotransmitter-related gene expression. Gene expression patterns of diabetic SMG-CG and SCG, prior to the development of NAD lesions, also differ from their age-matched non-diabetic counterparts. However, diabetes has ganglion-specific effects on gene expression; of approximately 110 transcripts that were differentially expressed between diabetic and control sympathetic ganglia, only 5 were differentially expressed as a result of diabetes in both SCG and SMG-CG. Genes involving synapse and mitochondrial structure and function, oxidative stress, and glycolysis were highly represented in the differentially expressed gene set. Differences in the number of synapse-related gene alterations in diabetic SMG-CG (18 genes) versus SCG (2 genes) prior to the onset of NAD may also well explain the selective development of NAD in the SMG-CG. These results provide support for the specificity of diabetes-modulated gene expression for selected neuronal subpopulations of sympathetic noradrenergic neurons.
- Open Access
- 1 May 2004
- Published by Oxford University Press (OUP) in Journal of Neuropathology & Experimental Neurology
- Vol. 63 (5) , 450-460
Experimental Rat Models of Types 1 and 2 Diabetes Differ in Sympathetic Neuroaxonal Dystrophy
Dysfunction of the autonomic nervous system is a recognized complication of diabetes, ranging in severity from relatively minor sweating and pupillomotor abnormality to debilitating interference with cardiovascular, genitourinary, and alimentary dysfunction. Neuroaxonal dystrophy (NAD), a distinctive distal axonopathy involving terminal axons and synapses, represents the neuropathologic hallmark of diabetic sympathetic autonomic neuropathy in man and several insulinopenic experimental rodent models. Although the pathogenesis of diabetic sympathetic NAD is unknown, recent studies have suggested that loss of the neurotrophic effects of insulin and/or insulin-like growth factor-I (IGF-I) on sympathetic neurons rather than hyperglycemia per se, may be critical to its development. Therefore, in our current investigation we have compared the sympathetic neuropathology developing after 8 months of diabetes in the streptozotocin (STZ)-induced diabetic rat and BB/ Wor rat, both models of hypoinsulinemic type 1 diabetes, with the BBZDR/Wor rat, a hyperglycemic and hyperinsulinemic type 2 diabetes model. Both STZ- and BB/Wor-diabetic rats reproducibly developed NAD in nerve terminals in the prevertebral superior mesenteric sympathetic ganglia (SMG) and ileal mesenteric nerves. The BBZDR/Wor-diabetic rat, in comparison, failed to develop superior mesenteric ganglionic NAD in excess of that of age-matched controls. Similarly, NAD which developed in axons of ileal mesenteric nerves of BBZDR/Wor rats was substantially less frequent than in BB/Wor- and STZ-rats. These data, considered in the light of the results of previous experiments, argue that hyperglycemia alone is not sufficient to produce sympathetic ganglionic NAD, but rather that it may be the diabetes-induced superimposed loss of trophic support, likely of IGF-I, insulin, or C-peptide, that ultimately causes NAD.
- 1 May 2004
- Published by Oxford University Press (OUP) in Journal of Neuropathology & Experimental Neurology
- Vol. 63 (5) , 450-460
Open AccessExperimental Rat Models of Types 1 and 2 Diabetes Differ in Sympathetic Neuroaxonal Dystrophy
Dysfunction of the autonomic nervous system is a recognized complication of diabetes, ranging in severity from relatively minor sweating and pupillomotor abnormality to debilitating interference with cardiovascular, genitourinary, and alimentary dysfunction. Neuroaxonal dystrophy (NAD), a distinctive distal axonopathy involving terminal axons and synapses, represents the neuropathologic hallmark of diabetic sympathetic autonomic neuropathy in man and several insulinopenic experimental rodent models. Although the pathogenesis of diabetic sympathetic NAD is unknown, recent studies have suggested that loss of the neurotrophic effects of insulin and/or insulin-like growth factor-I (IGF-I) on sympathetic neurons rather than hyperglycemia per se, may be critical to its development. Therefore, in our current investigation we have compared the sympathetic neuropathology developing after 8 months of diabetes in the streptozotocin (STZ)-induced diabetic rat and BB/ Wor rat, both models of hypoinsulinemic type 1 diabetes, with the BBZDR/Wor rat, a hyperglycemic and hyperinsulinemic type 2 diabetes model. Both STZ- and BB/Wor-diabetic rats reproducibly developed NAD in nerve terminals in the prevertebral superior mesenteric sympathetic ganglia (SMG) and ileal mesenteric nerves. The BBZDR/Wor-diabetic rat, in comparison, failed to develop superior mesenteric ganglionic NAD in excess of that of age-matched controls. Similarly, NAD which developed in axons of ileal mesenteric nerves of BBZDR/Wor rats was substantially less frequent than in BB/Wor- and STZ-rats. These data, considered in the light of the results of previous experiments, argue that hyperglycemia alone is not sufficient to produce sympathetic ganglionic NAD, but rather that it may be the diabetes-induced superimposed loss of trophic support, likely of IGF-I, insulin, or C-peptide, that ultimately causes NAD.
- 1 November 2003
- Published by Elsevier in The American Journal of Pathology
- Vol. 163 (5) , 2077-2091
Non-Obese Diabetic Mice Rapidly Develop Dramatic Sympathetic Neuritic Dystrophy
- 1 November 2003
- Published by Elsevier in The American Journal of Pathology
- Vol. 163 (5) , 2077-2091
Non-Obese Diabetic Mice Rapidly Develop Dramatic Sympathetic Neuritic Dystrophy
- 1 July 2003
- Published by Elsevier in The American Journal of Pathology
- Vol. 163 (1) , 21-28
Analysis of the Zucker Diabetic Fatty (ZDF) Type 2 Diabetic Rat Model Suggests a Neurotrophic Role for Insulin/IGF-I in Diabetic Autonomic Neuropathy
- 1 July 2003
- Published by Elsevier in The American Journal of Pathology
- Vol. 163 (1) , 21-28
Analysis of the Zucker Diabetic Fatty (ZDF) Type 2 Diabetic Rat Model Suggests a Neurotrophic Role for Insulin/IGF-I in Diabetic Autonomic Neuropathy
- 1 February 2002
- Published by Elsevier in Autonomic Neuroscience
- Vol. 96 (1) , 63-72
Age-related sympathetic ganglionic neuropathology: human pathology and animal models
- 1 February 2002
- Published by Elsevier in Autonomic Neuroscience
- Vol. 96 (1) , 63-72
Age-related sympathetic ganglionic neuropathology: human pathology and animal models
- 1 December 2001
- Published by Elsevier in Brain Research
- Vol. 921 (1-2) , 256-259
Neuronal preservation in the sympathetic ganglia of rats with chronic streptozotocin-induced diabetes
- 1 December 2001
- Published by Elsevier in Brain Research
- Vol. 921 (1-2) , 256-259
Neuronal preservation in the sympathetic ganglia of rats with chronic streptozotocin-induced diabetes
- 30 August 2000
- Published by Elsevier in Brain Research
- Vol. 876 (1-2) , 88-94
Effect of IGF-I and neurotrophin-3 on gracile neuroaxonal dystrophy in diabetic and aging rats
- 30 August 2000
- Published by Elsevier in Brain Research
- Vol. 876 (1-2) , 88-94
Effect of IGF-I and neurotrophin-3 on gracile neuroaxonal dystrophy in diabetic and aging rats